Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencySun, 30 Jun 2024 10:46:19 +0200Mon, 13 May 2024 16:17:00 +0200Human medicines European public assessment report (EPAR): Bexsero, meningococcal group B Vaccine (rDNA, component, adsorbed), Date of authorisation: 13/01/2013, Revision: 34, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/bexseroHuman medicines European public assessment report (EPAR): Bexsero, meningococcal group B Vaccine (rDNA, component, adsorbed), Date of authorisation: 13/01/2013, Revision: 34, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/bexseroMon, 13 May 2024 16:17:00 +0200Human medicineBexsero-H-C-2333-P46-014.1 : EPAR - Assessment Reporthttps://www.ema.europa.eu/system/files/documents/variation-report/wc500187839_en.pdfBexsero-H-C-2333-P46-014.1 : EPAR - Assessment Reporthttps://www.ema.europa.eu/system/files/documents/variation-report/wc500187839_en.pdfFri, 12 Jun 2015 02:00:00 +0200Human medicine